- Barr announces agreements on Nasacort AQ, Allegra D-12 and Allegra patent challenges (News-Medical-Net)
Barr Pharmaceuticals, Inc. today announced that its subsidiary, Barr Laboratories, Inc. has entered into separate settlement agreements related to ongoing patent challenges for Nasacort AQ (triamcinolone acetonide) nasal spray, Allegra D-12 Hour (fexofenadine hydrochloride 60mg and pseudoephedrine hydrochloride 120mg) extended-release tablets, and Allegra (fexofenadine) 30mg, 60mg and 180mg ...
- Perrigo Acknowledges Settlement of NASACORT(R) AQ Nasal Spray Patent Litigation (PR Newswire via Yahoo! Finance)
Perrigo Company today acknowledges the settlement of patent litigation brought by Sanofi-Aventis against Barr Laboratories, Inc. a subsidiary of Barr Pharmaceuticals, Inc. .
- Sanofi settles on Allegra, Nasacort generics in U.S. (Reuters via Yahoo! News)
France's Sanofi-Aventis has agreed to settle patent infringement suits in the United States with Barr Pharmaceuticals and Teva Pharmaceuticals over their generic copies of its allergy drugs Allegra and Nasacort.
- (AFX UK Focus) 2008-11-19 16:05 UPDATE 2-Sanofi allows Allegra, Nasacort copies in U.S. (Interactive Investor)
By Caroline Jacobs
- (AFX UK Focus) 2008-11-19 10:13 UPDATE 2-Sanofi allows Allegra, Nasacort copies in U.S. (Interactive Investor)
By Caroline Jacobs